Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT03907488
Brief Title: Immunotherapy (Nivolumab or Brentuximab Vedotin) Plus Combination Chemotherapy in Treating Patients With Newly Diagnosed Stage III-IV Classic Hodgkin Lymphoma

First Submitted : April 8, 2019
First Submitted that Met QC Criteria : April 8, 2019
First Posted : April 9, 2019

Last Update Submitted that Met QC Criteria : August 4, 2021
Last Update Posted : August 5, 2021 (Estimate)